Yusuke Matsuo

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Changes in serious infection and mortality among patients with ANCA-associated vasculitis during the COVID-19 pandemic: an interrupted time-series analysis of J-CANVAS.

Changes in serious infection and mortality among patients with ANCA-associated vasculitis during the COVID-19 pandemic: an interrupted time-series analysis of J-CANVAS.

Journal: EULAR rheumatology open

Published: August 01, 2026

Impact of parenting on patient-reported outcomes in female patients with systemic lupus erythematosus: A cross-sectional study of the LUNA registry.

Impact of parenting on patient-reported outcomes in female patients with systemic lupus erythematosus: A cross-sectional study of the LUNA registry.

Journal: Lupus

Published: July 30, 2026

Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state.

Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state.

Journal: Lupus

Published: July 29, 2026

The relationship between obesity and disease relapse in systemic lupus erythematosus: a retrospective cohort study using the LUNA registry.

The relationship between obesity and disease relapse in systemic lupus erythematosus: a retrospective cohort study using the LUNA registry.

Journal: Frontiers in immunology

Published: January 06, 2026

Disentangling Temporal Factors in Organ Damage Accrual in Systemic Lupus Erythematosus: Onset-Age, Onset-Era, and Aging in the Japanese LUNA Registry.

Disentangling Temporal Factors in Organ Damage Accrual in Systemic Lupus Erythematosus: Onset-Age, Onset-Era, and Aging in the Japanese LUNA Registry.

Journal: Modern rheumatology

Published: December 11, 2025

Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicentre cohort study (J-CANVAS).

Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicentre cohort study (J-CANVAS).

Journal: Modern rheumatology

Published: December 08, 2025

Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS).

Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS).

Journal: Arthritis research & therapy

Published: November 29, 2025

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus.

Comparison of predictive validity of the Lupus Patient-Reported Outcome and Short-Form-12 for damage accrual in systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: October 16, 2025

Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVAS.

Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVAS.

Journal: International journal of rheumatic diseases

Published: September 24, 2025

The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosus.

The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: September 01, 2025

Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS).

Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS).

Journal: Clinical and experimental rheumatology

Published: July 07, 2025

Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVAS.

Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVAS.

Journal: Modern rheumatology

Published: June 26, 2025

Showing 1-12 of 41

Last Updated: 09/26/2026